| Literature DB >> 27894453 |
Craig Erker1, Paul Harker-Murray1, Julie-An Talano2.
Abstract
Familial hemophagocytic lymphohistiocytosis (FHL) and Langerhans cell histiocytosis (LCH) are histiocytic diseases that occur most commonly in young children. Improvements in recognition and treatment have been substantial for both diseases in the past decade, although early and late morbidity continue to be major concerns. These two diagnoses behave differently, although the clinical spectra for both diseases are diverse and can lead to confusion and delays in diagnosis and treatment. This article focuses on the clinical and genetic spectrum of FHL as well as the clinical and treatment variations of LCH. Copyright ÂEntities:
Keywords: Familial hemophagocytic lymphohistiocytosis (FHL); Hemophagocytic lymphohistiocytosis (HLH); Histiocytic disorders; Langerhans cell histiocytosis (LCH)
Mesh:
Year: 2017 PMID: 27894453 DOI: 10.1016/j.pcl.2016.08.006
Source DB: PubMed Journal: Pediatr Clin North Am ISSN: 0031-3955 Impact factor: 3.278